Ronald W. McClurg

Insider Reports History

Entity
Individual
Location
C/O Neuroone Medical Technologies Corp, 7599 Anagram Dr, Eden Prairie, MN
Signature
/s/ Stephanie Swan, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ronald W. McClurg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NEUROONE MEDICAL TECHNOLOGIES Corp Chief Financial Officer Common Stock 444K $378K $0.85 Apr 4, 2025 Direct
NEUROONE MEDICAL TECHNOLOGIES Corp Chief Financial Officer Option to Purchase Common Stock 250K Apr 17, 2025 Direct
Healthcare Triangle, Inc. Director Incentive Stock Option (Right To Buy) 10K Mar 12, 2024 Direct

Insider Reports Filed by Ronald W. McClurg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NMTC NEUROONE MEDICAL TECHNOLOGIES Corp Apr 17, 2025 1 $0 4 Apr 21, 2025 Chief Financial Officer
NMTC NEUROONE MEDICAL TECHNOLOGIES Corp Apr 4, 2025 1 $100K 4 Apr 7, 2025 Chief Financial Officer
HCTI Healthcare Triangle, Inc. Mar 12, 2024 1 $0 4 Mar 13, 2024 Director
NMTC NEUROONE MEDICAL TECHNOLOGIES Corp Feb 18, 2024 1 $0 4 Feb 21, 2024 Chief Financial Officer
NMTC NEUROONE MEDICAL TECHNOLOGIES Corp Nov 9, 2023 1 $0 4 Nov 13, 2023 Chief Financial Officer
NMTC NEUROONE MEDICAL TECHNOLOGIES Corp Sep 13, 2023 1 $50K 4 Sep 14, 2023 Chief Financial Officer
NMTC NEUROONE MEDICAL TECHNOLOGIES Corp Apr 21, 2023 2 $0 4 Apr 25, 2023 Chief Financial Officer
HCTI Healthcare Triangle, Inc. Jan 27, 2023 0 $0 3 Feb 6, 2023 Director
NMTC NEUROONE MEDICAL TECHNOLOGIES Corp Jun 15, 2022 1 $10.2K 4 Jun 16, 2022 Chief Financial Officer
NMTC NEUROONE MEDICAL TECHNOLOGIES Corp Jun 10, 2022 1 $14.8K 4 Jun 14, 2022 Chief Financial Officer
NMTC NEUROONE MEDICAL TECHNOLOGIES Corp May 20, 2022 2 $25.2K 4 May 24, 2022 Chief Financial Officer
BTCY BIOTRICITY INC. May 4, 2022 0 $0 3 May 16, 2022 Director
NMTC NEUROONE MEDICAL TECHNOLOGIES Corp Feb 3, 2022 1 $0 4 Feb 4, 2022 Chief Financial Officer